Skip to main content
OpenTrials

Clinical trial condition

Advanced Solid Tumor

Explore clinical trials studying Advanced Solid Tumor. Study availability and eligibility vary by location and protocol.

514 public trials 240 recruiting studies
Refine in advanced search Browse all conditions

Advanced Solid Tumor trial results

Active, Not Recruiting

First in Human Study of TORL-3-600 in Participants With Advanced Cancer

NCT05948826

Conditions
Advanced Solid Tumor, Colonic Diseases, Colorectal Cancer, +10 more
Locations
  • Providence Medical Foundation Fullerton, California, United States
  • UCLA - JCCC Clinical Research Unit Los Angeles, California, United States
  • Sarah Cannon Research Institute Denver, Colorado, United States
  • Fort Wayne Medical Oncology and Hematology Inc. Fort Wayne, Indiana, United States
View Trial Details
Active, Not Recruiting

Study of TPX-0022 in Patients With Advanced NSCLC, Gastric Cancer or Solid Tumors Harboring Genetic Alterations in MET

NCT03993873

Conditions
Adenocarcinoma, Adenocarcinoma of Lung, Advanced Solid Tumor, +27 more
Locations
  • Local Institution - 2102 La Jolla, California, United States
  • Local Institution - 2108 Orange, California, United States
  • Local Institution - 2105 Denver, Colorado, United States
  • Local Institution - 2111 Chicago, Illinois, United States
View all 24 locations
View Trial Details
Active, Not Recruiting

A Phase 1/2a Study of IMM-1-104 in Participants With Advanced or Metastatic Solid Tumors

NCT05585320

Conditions
Adenocarcinoma, Advanced Solid Tumor, Bronchial Neoplasms, +29 more
Locations
  • Mayo Clinic Scottsdale, Arizona, United States
  • City of Hope Duarte, California, United States
  • University of California San Diego San Diego, California, United States
  • Sarcoma Oncology Center Santa Monica, California, United States
View all 20 locations
View Trial Details
Active, Not Recruiting

A Study of SNS-101 (Anti VISTA) Monotherapy and in Combination With Cemiplimab in Patients With Advanced Solid Tumors

NCT05864144

Conditions
Adenocarcinoma, Adnexal Diseases, Advanced Cancer, +101 more
Locations
  • UCLA Hematology/Oncology Los Angeles, California, United States
  • University of Colorado Cancer Center - Anschutz Medical Aurora, Colorado, United States
  • Norton Healthcare Louisville, Kentucky, United States
  • Henry Ford Cancer Detroit, Michigan, United States
View Trial Details
Active, Not Recruiting

A Phase 1 Clinical Study of NXP800 in Subjects With Advanced Cancers and Expansion in Subjects With Ovarian Cancer

NCT05226507

Conditions
ARID1A Gene Mutation, Adenocarcinoma, Adnexal Diseases, +24 more
Locations
  • Honor Health Phoenix, Arizona, United States
  • UC San Diego Health - Moores Cancer Center La Jolla, California, United States
  • University of Colorado Cancer Center Aurora, Colorado, United States
  • Yale Gynecologic Oncology New Haven, Connecticut, United States
View all 22 locations
View Trial Details
Active, Not Recruiting

A Phase 1/2 Study of OBI-992 in Subjects With Advanced Solid Tumors

NCT06480240

Conditions
Advanced Solid Tumor
Locations
  • California Clinical Trials Medical Group (CCTMG) Glendale, California, United States
  • Scripps Green Hospital La Jolla, California, United States
  • Karmanos Cancer Institute Detroit, Michigan, United States
  • The University of Texas MD Anderson Cancer Center Houston, Texas, United States
View Trial Details
Active, Not Recruiting

QTX3046 in Patients With KRAS G12D Mutations

NCT06428500

Conditions
Advanced Solid Tumor
Locations
  • South Texas Accelerated Research Therapeutics, LLC Midwest Grand Rapids, Michigan, United States
  • Duke Cancer Center Durham, North Carolina, United States
  • The University of Texas MD Anderson Cancer Center Houston, Texas, United States
  • South Texas Accelerated Research Therapeutics, LLC San Antonio San Antonio, Texas, United States
View Trial Details
Active, Not Recruiting

Safety, PK and Efficacy of ONC-392 in Monotherapy and in Combination of Anti-PD-1 in Advanced Solid Tumors and NSCLC

NCT04140526

Conditions
Adenocarcinoma, Adenoid Cystic Carcinoma, Adnexal Diseases, +94 more
Locations
  • Highlands Oncology Group Springdale, Arkansas, United States
  • University of California at Davis Davis, California, United States
  • The Oncology Institute of Hope and Innovation Downey, California, United States
  • City of Hope Cancer Center Duarte, California, United States
View all 37 locations
View Trial Details

Related conditions